Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Pacific Biosciences of California    P09

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
03/24/2017 03/27/2017 03/28/2017 03/29/2017 03/28/2017 Date
4.615(c) 4.605(c) 4.507(c) 5.02(c) 4.507 Last
0 0 0 0 0 Volume
-0.99% -0.22% -2.13% +11.38% -2.13% Change
More quotes
Financials ($)
Sales 2017 113 M
EBIT 2017 -81,5 M
Net income 2017 -85,1 M
Debt 2017 0,70 M
Yield 2017 -
Sales 2018 147 M
EBIT 2018 -62,4 M
Net income 2018 -65,3 M
Finance 2018 0,22 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 3,99x
EV / Sales2018 3,05x
Capitalization 450 M
More Financials
Company
Pacific Biosciences of California, Inc. engages in the research, development, and manufacture of sequencing systems for genetic analysis.It operates through the following geographical segments: North America, Europe, and Asia.It offers deoxyribonucleic acid sequencing, third generation sequencing... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
03/27 PACIFIC BIOSCIENCES OF CALIFORNIA : Sources Sought Notice - Pacific Biosciences ..
03/16 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Substrates, Systems and Me..
03/06 PACIFIC BIOSCIENCES OF CALIFORNIA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINA..
02/13 SMRT Sequencing to be Featured in More Than 35 Presentations at the Annual AG..
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA : reports 4Q loss
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Other Events, Financial Statements and Ex..
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
02/02 Pacific Biosciences Announces Fourth Quarter 2016 Financial Results
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Modular Nucleotide Composi..
02/02 PACIFIC BIOSCIENCES OF CALIFORNIA : Patent Issued for Filter Architecture for An..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
03/28DJPHILIPS : to Buy Australian pharmacy Sleep Services Firm
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
More sector news : Advanced Medical Equipment & Technology - NEC
Advertisement
Chart PACIFIC BIOSCIENCES OF CAL
Duration : Period :
Pacific Biosciences of Cal Technical Analysis Chart | P09 | US69404D1081 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 7,42 $
Spread / Average Target 53%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Executive VP
Stephen W. Turner Chief Technical Officer & Vice President
Jonas Korlach Chief Scientific Officer
Brook H. Byers Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF..23.28%450
THERMO FISHER SCIENTIF..9.60%60 370
DANAHER CORPORATION10.34%59 546
BOSTON SCIENTIFIC CORP..14.19%33 678
PHILIPS2.57%29 901
INTUITIVE SURGICAL, IN..20.55%28 076
More Results